Gill Smollan
- Molecular Medicine top 0.5%
- Applied Microbiology and Biotechnology top 0.5%
- Epidemiology top 10%
- Infectious Diseases top 5%
- Endocrinology top 2%
- Co-authors
- Mitchell J. SchwaberYehuda CarmeliNathan KellerBina RubinovitchDebby Ben-DavidItamar ShalitA IsraeliBaruch Lev
- Topics
- Antibiotic Resistance in Bacteria (9 papers)Antimicrobial Resistance in Staphylococcus (6 papers)Antibiotic Use and Resistance (4 papers)
- Partner nations
- IsraelUnited StatesCzechia
In The Last Decade
Gill Smollan
23 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 92
- Molecular Medicine 662
- Applied Microbiology and Biotechnology 281
- Epidemiology 277
- Infectious Diseases 273
- Endocrinology 264
Countries citing papers authored by Gill Smollan
This map shows the geographic impact of Gill Smollan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Smollan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Smollan more than expected).
Fields of papers citing papers by Gill Smollan
This network shows the impact of papers produced by Gill Smollan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Smollan. The network helps show where Gill Smollan may publish in the future.
Co-authorship network of co-authors of Gill Smollan
This figure shows the co-authorship network connecting the top 25 collaborators of Gill Smollan. A scholar is included among the top collaborators of Gill Smollan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Smollan. Gill Smollan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 22 | |
| 5 | 44 | |
| 6 | 27 | |
| 7 | 12 | |
| 8 | 5 | |
| 9 | 24 | |
| 10 | 2 | |
| 11 | 9 | |
| 12 | 74 | |
| 13 | 81 | |
| 14 | 331 | |
| 15 | 16 | |
| 16 | 31 | |
| 17 | 140 | |
| 18 | 66 | |
| 19 | 37 | |
| 20 | Development of antimicrobial drug resistance among Shigellas isolated at an Israeli hospital from 1977 through 1990. | 14 |
About Gill Smollan
Gill Smollan is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (281 citations), Molecular Medicine (662 citations) and Endocrinology (264 citations). Gill Smollan has collaborated with scholars based in Israel, United States and Czechia. Frequent co-authors include Mitchell J. Schwaber, Yehuda Carmeli, Nathan Keller, Bina Rubinovitch, Debby Ben-David, Itamar Shalit, A Israeli, Baruch Lev, Ester Solter and Yasmin Maor. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.